Our study on ECC demonstrated that OCT4 promoted survivin expression to inhibit apoptosis in cancer cells [2] and promoted CCND1 expression and activated CDK4/6 activity to accelerate cell cycle progression [8]. The gene discussed is CDK4; the disease is cancer.